Inhibition of in vitro macrophage-induced low density lipoprotein oxidation by thyroid compounds

Journal of Endocrinology

Volumn 177, Issue 1, 2003, Pages 137-146

  Oziol, L ^a   Faure, P ^a   Bertrand, N ^a,b   Chomard, P ^a,b  

^a UFR Sci Pharmaceutiques Biologiques   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3,3',5' TRIIODOTHYRONINE; ACETIC ACID DERIVATIVE; COPPER ION; LACTATE DEHYDROGENASE; LIOTHYRONINE; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THYROID HORMONE DERIVATIVE; THYRONINE; THYROXINE; TIRATRICOL;

ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CELL STRAIN U937; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; LIPID OXIDATION; LIPID PEROXIDATION; MACROPHAGE; MONOCYTE; OXIDATION REDUCTION REACTION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW;

HUMANS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MACROPHAGES; THIOBARBITURIC ACID REACTIVE SUBSTANCES; THYROID HORMONES; U937 CELLS;

EID: 0038325668     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1770137     Document Type: Review

References (45)

1. Bianchi G, Solaroli E, Accheroni V, Grossi G, Bargossi AM, Melchionda N & Marchesini G 1999 Oxidative stress and anti-oxidant metabolites in patients with hyperthyroidism: effect of treatment. Hormone and Metabolic Research 31 620-624.
2. Burger AG, Engler D, Buergi U, Weissel M, Steiger G, Ingbar SH, Rosin RE & Babior BM 1983 Ether link cleavage is the major pathway of iodothyronine metabolism in the phagocytosing human leukocyte and also occurs in vivo in the rat. Journal of Clinical Investigation 71 935-949.
3. Burman KD, Latham KR, Djuh YY, Smallridge RC, Tseng YC, Lukes YG, Maunder R & Wartofsky L 1980 Solubilized nuclear thyroid hormone receptors in circulating human mononuclear cells. Journal of Clinical Endocrinology and Metabolism 51 106-116.
4. Carr AC, McCall MR & Frei B 2000 Oxidation of LDL by myeloperoxidase and reactive nitrogen species: reaction pathways and antioxidant protection. Arteriosclerosis Thrombosis and Vascular Biology 20 1716-1723.
5. Cash WD, Carlson HE, Cox SW, Ekong EA, Epstein JS & Sigel RM 1967 Studies on the antioxidant action of thyroxine and related compounds. Journal of Medicinal Chemistry 10 1081-1085.
6. Chisolm GM & Steinberg D 2000 The oxidative modification hypothesis of atherogenesis: an overview. Free Radical Biology and Medicine 28 1815-1826.
7. Chisolm GM, Hazen SL, Fox PL & Cathcart MK 1999 The oxidation of lipoproteins by monocytes-macrophages. Journal of Biological Chemistry 274 25959-25962.
8. Chomard P, Seguin C, Loireau A, Autissier N & Artur Y 1998 Effects of iodotyrosines, thyronines, iodothyroacetic acids and thyromimetic analogues on in vitro copper-induced oxidation of low-density lipoproteins. Biochemical Pharmacology 55 1591-1601.
9. Costantini F, Pierdomenico SD, De Cesare D, De Remigis P, Bucciarelli T, Bittolo Bon G, Cazzolato G, Nubile G, Guagnano MT, Sensi S, Cuccurullo F & Mezzetti A 1998 Effect of thyroid function on LDL oxidation. Arteriosclerosis Thrombosis and Vascular Biology 18 732-737.
10. Danese MD, Ladenson PW, Meinert CL & Powe NR 2000 Effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. Journal of Clinical Endocrinology and Metabolism 85 2993-3001.
11. Diekman T, Demacker PNM, Kastelein JJP, Stalenhoef AFH & Wiersinga WM 1998 Increased oxidizability oflow-density lipoproteins in hypothyroidism. Journal of Clinical Endocrinology and Metabolism 83 1752-1755.
12. 3) reduced in vitro copper-induced LDL oxidation by different mechanisms. Chemistry and Physics of Lipids 101 167 (Symposium topic/number T3/P1).
13. Fernandez V & Videla LA 1995 On the mechanism of thyroid hormone-induced respiratory burst activity in rat polymorphonuclear leukocytes. Free Radical Biology and Medicine 19 359-363.
14. Fuhrman B, Oiknine J & Aviram M 1994 Iron induces lipid peroxidation in cultured macrophages, increases their ability to oxidatively modify LDL, and affects their secretory properties. Atherosclerosis 111 65-78.
15. Green WL 1994 Ether-link cleavage of iodothyronines. In Thyroid Hormone Metabolism. Molecular Biology and Alternate Pathways, pp 199-221. Eds SY Wu & TJ Visser. Boca Raton: CRC Press Inc.
16. Hanna AN, Feller DR, Witiak DT & Newman HAI 1993 Inhibition of low density lipoprotein oxidation by thyronines and probucol. Biochemical Pharmacology 45 753-762.
17. Hanna AN, Titterington LC, Lantry LE, Stephens RE & Newman HAI 1995 Thyronines and probucol inhibition of human capillary endothelial cell-induced low density lipoprotein oxidation. Biochemical Pharmacology 50 1627-1633.
18. Hulbert AJ 2000 Thyroid hormones and their effects: a new perspective. Biological Reviews of the Cambridge Philosophical Society 75 519-631.
19. Jorgensen EC 1981 Thyromimetic and antithyroid drugs. In Burger's Medicinal Chemistry, edn 4, part 3, pp 103-145. Ed. ME Wolff. New York: John Wiley & Sons.
20. Kaplan M & Aviram M 1999 Oxidized low density lipoprotein: atherogenic and proinflammatory characteristics during macrophage foam cell formation. An inhibitory role for nutritional antioxidants and serum paraoxonase. Clinical Chemistry and Laboratory Medicine 37 777-787.
21. Klebanoff SJ & Green WL 1973 Degradation of thyroid hormones by phagocytosing human leukocytes. Journal of Clinical Investigation 52 60-72.
22. Kleinveld HA, Hak-Lemmers HLM, Stalenhoef AFH & Demacker PNM 1992 Improved measurement of low-density-lipoprotein susceptibility to copper-induced oxidation: application of a short procedure for isolating low-density lipoprotein. Clinical Chemistry 38 2066-2072.
23. Kragie L 1994 Membrane iodothyronine transporters part 1: review of physiology. Endocrine Research 20 319-341.
24. Kragie L 1996 Membrane iodothyronine transporters part 2: review of protein biochemistry. Endocrine Research 22 95-119.
25. Lamb DJ, Mitchinson MJ & Leake DS 1995 Transition metal ions within human atherosclerotic lesions can catalyse the oxidation of low density lipoprotein by macrophages. FEBS Letters 374 12-16.
26. Liu WK, Wong CC & Mak NK 1989 Localization of thyroid hormone in subpopulations of rat alveolar macrophages. Histochemical Journal 21 115-121.
27. Magsino CH Jr, Hamouda W, Ghanim H, Browne R, Aljada A & Dandona P 2000 Effect of triiodothyronine on reactive oxygen species generation by leukocytes, indices of oxidative damage and antioxidant reserve. Metabolism 49 799-803.
28. Marchant CE, Van Der Veen C, Law NS, Hardwick SJ, Carpenter KLH & Mitchinson MJ 1996 Oxidation of low-density lipoprotein by human monocyte-macrophages results in toxicity to the oxidising culture. Free Radical Research 24 333-342.
29. Markwell MAK, Haas SM, Buber LL & Tolbert NE 1978 A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Analytical Biochemistry 87 206-210.
30. Martinez Triguero ML, Hernandez Mijares A, Nguyen TT, Munoz ML, Pena H, Morillas C, Lorente D, Lluch I & Molina E 1998 Effect of thyroid hormone replacement on lipoprotein(a), lipids, and apolipoproteins in subjects with hypothyroidism. Mayo Clinic Proceedings 73 837-841.
31. Meinhold H & Buchholz R 1986 In vivo formation of diiodotyrosine by extrathyroidal thyroxine ether-link cleavage and effects of mononitrotyrosine on this pathway in the rat. Endocrinology 118 2305-2311.
32. Müller K, Carpenter KLH & Mitchinson MJ 1998 Cell-mediated oxidation of LDL: comparison of different cell types of the atherosclerotic lesion. Free Radical Research 29 207-220.
33. O'Brien T, Katz K, Hodge D, Nguyen T, Kottke BA & Hay ID 1997 The effect of the treatment of hypothyroidism and hyperthyroidism on plasma lipids and apolipoproteins AI, AII and E. Clinical Endocrinology 46 17-20.
34. Oziol L, Faure P, Vergely C, Rochette L, Artur Y & Chomard P 2001 In vitro free radical scavenging capacity of thyroid hormones and structural analogues. Journal of Endocrinology 170 197-206.
35. Pereira B, Rosa LF, Safi DA, Bechara EJ & Curi R 1994 Control of superoxide dismutase, catalase and glutathione peroxidase activities in rat lymphoid organs by thyroid hormones. Journal of Endocrinology 140 73-77.
36. Pereira B, Rosa LF, Safi DA, Bechara EJ & Curi R 1995 Hormonal regulation of superoxide dismutase, catalase and glutathione peroxidase activities in rat macrophages. Biochemical Pharmacology 50 2093-2098.
37. Sundaram V, Hanna AN, Konem L, Newman HAI & Falko JM 1997 Both hypothyroidism and hyperthyroidism enhance low density lipoprotein oxidation. Journal of Clinical Endocrinology and Metabolism 82 3421-3424.
38. Takeda T, Suzuki S, Liu RT & DeGroot LJ 1995 Triiodothyroacetic acid has unique potential for therapy of resistance to thyroid hormone. Journal of Clinical Endocrinology and Metabolism 80 2033-2040.
39. Van Reyk DM, Jessup W & Dean RT 1999 Prooxidant and antioxidant activities of macrophages in metal-mediated LDL oxidation: the importance of metal sequestration. Arteriosclerosis Thrombosis and Vascular Biology 19 1119-1124.
40. Van Zyl JM, Basson K & Van der Walt BJ 1989 Stimulation of the chlorinating activity of human myeloperoxidase by thyroid hormones and analogues. Hormone and Metabolic Research 21 441-444.
41. Videla LA, Correa L, Rivera M & Sir T 1993 Zymosan-induced lumiol-amplified chemiluminescence of whole blood phagocytes in experimental and human hyperthyroidism. Free Radical Biology and Medicine 14 669-675.
42. Witztum JL & Steinberg D 2001 The oxidative modification hypothesis of atherosclerosis; does it hold for humans? Trends in Cardiovascular Medicine 11 93-102.
43. Xing X, Baffic J & Sparrow CP 1998 LDL oxidation by activated monocytes: characterization of the oxidized LDL and requirement for transition metal ions. Journal of Lipid Research 39 2201-2208.
44. Yuan XM & Brunk UT 1998 Iron and LDL-oxidation in atherogenesis. Acta Pathologica, Microbiologica et Immunologica Scandinavica 106 825-842.
45. Yuan XM, Anders WL, Olsson AG & Brunk UT 1996 Iron in human atheroma and LDL oxidation by macrophages following erythrophagocytosis. Atherosclerosis 124 61-73.